Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01394939
What this trial is testing

Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma

Who this might be right for
Colorectal CarcinomaCRC
Jennerex Biotherapeutics 52
Testing effectiveness (Phase 2)Study completedNCT01251575
What this trial is testing

Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant

Who this might be right for
Adult Acute Lymphoblastic LeukemiaAdult Acute Myeloid LeukemiaAdult Diffuse Large B-Cell Lymphoma+21 more
Fred Hutchinson Cancer Center 77
Early research (Phase 1)Ended earlyNCT00376519
What this trial is testing

Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+3 more
Masonic Cancer Center, University of Minnesota 3
Not applicableStudy completedNCT00786019
What this trial is testing

Influence of Endothelial Function on Central and Peripheral Causes Of Exercise Impairment in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
University of Colorado, Denver 47
Testing effectiveness (Phase 2)UnknownNCT05668767
What this trial is testing

Surufatinib in Combination of Durvalumab and EP/EC in the Firstly-line Treatment of ES-SCLC

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Beijing Chest Hospital 20
Early research (Phase 1)Ended earlyNCT05289492
What this trial is testing

Study of Novel Regimens in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
iTeos Therapeutics 16
Large-scale testing (Phase 3)Study completedNCT03856411
What this trial is testing

Evaluate the Efficacy and Safety of Toripalimab or Placebo Combined With Chemotherapy in Treatment-naive Advanced NSCLC

Who this might be right for
Treatment-naive Advanced Non-small Cell Lung Cancer
Shanghai Junshi Bioscience Co., Ltd. 465
Not applicableStudy completedNCT04492371
What this trial is testing

COVID-19 Infection and Multiple Myeloma

Who this might be right for
Multiple MyelomaCovid19Corona Virus Infection
Stichting European Myeloma Network 1,054
Not applicableUnknownNCT04671368
What this trial is testing

Diagnostic Efficiency of Artificial Intelligence for Surgical Neuropathology

Who this might be right for
Central Nervous System Neoplasms
Jinsong Wu 141
Not applicableEnded earlyNCT03777410
What this trial is testing

Mass Accumulation Rate (MAR) as a Predictive Biomarker in Multiple Myeloma

Who this might be right for
Multiple Myeloma in Relapse
Travera Inc 33
Not applicableStudy completedNCT04804397
What this trial is testing

Effects of Sucrose Added Blind to the Diet Over Eight Weeks on Body Mass and Weight in Men

Who this might be right for
Overweight
University of Hull 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT04124497
What this trial is testing

A Trial for Relapsed and Relapsed/Refractory Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaDeletion 17P Syndrome
Fondazione EMN Italy Onlus 45
Testing effectiveness (Phase 2)Study completedNCT00051597
What this trial is testing

A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies

Who this might be right for
Hodgkin DiseaseLymphoma, Large-CellSarcoma, Kaposi+2 more
Seagen Inc. 70
Not applicableStudy completedNCT03951220
What this trial is testing

The Development and Pilot Testing of a New MR Imaging Protocol to Quantify Myeloma Disease Burden and Bone Loss

Who this might be right for
MyelomaMonoclonal Gammopathy of Undetermined Significance (MGUS)Smouldering Myeloma
Oxford University Hospitals NHS Trust 67
Not applicableUnknownNCT06205823
What this trial is testing

Compare Clinical Outcomes Between Advanced Immunotherapy and Classical Immunochemotherapy in RRMM

Who this might be right for
Myeloma Multiple
Seoul St. Mary's Hospital 1,600
Testing effectiveness (Phase 2)Looking for participantsNCT05789303
What this trial is testing

Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma

Who this might be right for
Multiple MyelomaRelapse Multiple Myeloma
University of Chicago 83
Not applicableEnded earlyNCT03607682
What this trial is testing

Tumor-Treating Fields Therapy in Preventing Brain Tumors in Participants With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung Carcinoma
Vanderbilt-Ingram Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT01572480
What this trial is testing

Carfilzomib, Lenalidomide, and Dexamethasone for Smoldering Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI) 55
Early research (Phase 1)Study completedNCT00005946
What this trial is testing

Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Maryland, Baltimore
Large-scale testing (Phase 3)Not Yet RecruitingNCT06102161
What this trial is testing

Wedge Resection for Ground-glass Opacity-featured Lung Cancer (ECTOP-1020)

Who this might be right for
Lung CancerWedge ResectionGround-glass Opacity
Fudan University 286
Next Page